Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

RenalytixAI to Participate in the Stifel 2020 Healthcare Conference

November 13, 2020
NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today announced the

Stifel 2020 Healthcare Conference

November 13, 2020
RNS Number : 1993F Renalytix AI PLC 13 November 2020     Renalytix AI plc (" RenalytixAI " or the " Company ")   RenalytixAI to Participate in the Stifel 2020 Healthcare Conference   NEW YORK , November 13, 2020   - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX), an artificial intelligence-enabled

Change of Adviser

November 6, 2020
RNS Number : 4449E Renalytix AI PLC 06 November 2020       Renalytix AI plc (" RenalytixAI " or the " Company ")   Change of adviser   NEW YORK , November 6, 2020    - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on

Posting of Annual Report & Accounts and Notice of AGM

November 2, 2020
NEW YORK, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, confirms that the

Posting of Annual Report & Accounts &Notice of AGM

November 2, 2020
RNS Number : 9886D Renalytix AI PLC 02 November 2020       Renalytix AI plc (" RenalytixAI " or the " Company ")   Posting of Annual Report & Accounts and Notice of AGM   NEW YORK , November 2, 2020    - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro

Full Year Report

October 27, 2020
RNS Number : 3088D Renalytix AI PLC 27 October 2020     Renalytix AI plc (" RenalytixAI " or the " Company ")   Full Year Report   NEW YORK , October 27, 2020   - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing

Notice of Results

October 16, 2020
RNS Number : 2682C Renalytix AI PLC 16 October 2020       Renalytix AI plc (" RenalytixAI " or the " Company ")   Notice of results Analyst and Investor presentations   RenalytixAI To Announce Financial Results for Full Year Ended June 30, 2020 and Provide Corporate Update   NEW YORK , October 16,
Displaying 1 - 10 of 136